A kinetic approach to the immunology of cancer: stationary states properties of effector-target cell reactions.

We present a kinetic model of the onset of a tumor which involves the coupling of three principal phenomena: 1. (1) the transformation of normal into neoplastic cells, 2. (2) the replication of transformed cells, 3. (3) the immunological interaction of the host organism with transformed cells and/or oncogenic viruses. We assume that the immunological component has two opposite (destructing and facilitating) functions, each of which is regulated by activators and inhibitors. In this paper our analysis is devoted to the cell-mediated neoplastic cell destruction and its negative regulation by blocking factors or by other immunosuppressive agents. We assume that the immunological system may reach different stationary states (nonactivated, activated, suppressed, etc.). In each of these immunological stationary states, Michaelian-like kinetics for the cell-mediated cytotoxic reaction allow to describe the homogeneous stationary states of the neoplastic cell population in term of three adimensional parameters: (1) α, which represents the relative rate of cellular transformation; (2) β, which characterizes the relative rate of neoplastic cell destruction, and (3) θ, α parameter whose value determines the presence of a metastable region for the neoplastic transition of the tissue. The application of our model to the kinetic analysis of the immunological rejection of MSV-M induced tumors confirms our kinetic hypotheses and predicts the minimum ratio of aggressor to target cells that must be reached within the tumor mass to obtain a rejection. Since during rejection this level is not attained with the immune T-cells, we suggest additional co-operative mechanisms involving antibodies and other effector cell types. In the framework of our model we propose the following conclusions: 1. (1) Under physiological conditions tissues contain at least, one neoplastic cell to 1014–1018 normal cells, suggesting that they are exempted from neoplastic cells. 2. (2) The cell to cell cytotoxic activity of the different types of effectors seems to increase in the order: activated macrophages < immune T lymphocytes and natural activity of T lymphocytes. 3. (3) Whereas the cytotoxic activity of T lymphocytes is sufficiently high to cope with allogenic tumor rejection, in syngeneic tumor systems a complex interaction between differejnt effector cells and humoral factors must certainly take place in order to obtain a successful surveillance against cancer. 4. (4) The transition of normal to neoplastic tissues may bear some analogy with metastability phenomena.

[1]  G. Shellam Gross‐virus‐induced lymphoma in the rat. V. Natural cytotoxic cells are non‐t cells , 1977, International journal of cancer.

[2]  J. Levy,et al.  Cell‐mediated immune reaction against tumors induced by oncornaviruses. II. Nature of the effector cells in tumor‐cell cytolysis , 1973, International journal of cancer.

[3]  W. Looney,et al.  Cell proliferation and tumor growth in hepatomas 3924A. , 1971, Cancer research.

[4]  S. Perry,et al.  The cell cycle of leukemia L1210 cells in vivo. , 1967, Cancer research.

[5]  J. Denekamp The cellular proliferation kinetics of animal tumors. , 1970, Cancer research.

[6]  D. B. Amos,et al.  Selective cellular natural killing against human leukaemic T cells and thymus , 1977, Nature.

[7]  L. Chieco‐Bianchi,et al.  TUMOR INDUCTION BY MURINE SARCOMA VIRUS IN AKR AND C58 MICE , 1974, The Journal of experimental medicine.

[8]  M. Greaves,et al.  A Surface Antigen Marker for Human Monocytes , 1975, Scandinavian journal of immunology.

[9]  J. Levy,et al.  The murine sarcoma virus-induced tumor: exception or general model in tumor immunology? , 1977, Advances in cancer research.

[10]  B. Chapuis,et al.  Quantitative assay of the lytic action of immune lymphoid cells on 51-Cr-labelled allogeneic target cells in vitro; inhibition by isoantibody and by drugs. , 1968, Immunology.

[11]  J. Folkman The vascularization of tumors. , 1976, Scientific American.

[12]  S. Y. Lee Current status of the host-mediated L5178Y system for detecting chemical mutagens. , 1973, Environmental health perspectives.

[13]  F. Plata,et al.  Murine sarcoma virus (msv)‐induced tumors in mice. I. Distribution of msv‐immune cytolytic t lymphocytes in vivo , 1977, International journal of cancer.

[14]  S. Russell,et al.  The cellular events associated with regression and progression of murine (moloney) sarcomas , 1974, International journal of cancer.

[15]  R. Evans,et al.  Cooperation of Immune Lymphoid Cells with Macrophages in Tumour Immunity , 1970, Nature.

[16]  M. Burnet IMMUNOLOGICAL FACTORS IN THE PROCESS OF CARCINOGENESIS. , 1964, British medical bulletin.

[17]  R. Evans MACROPHAGES IN SYNGENEIC ANIMAL TUMOURS , 1972, Transplantation.

[18]  S. Eccles,et al.  Macrophage content of tumours in relation to metastatic spread and host immune reaction , 1974, Nature.

[19]  I. Hellstrom,et al.  Lymphocyte-mediated cytotoxicity and blocking serum activity to tumor antigens. , 1974, Advances in immunology.

[20]  C. O'toole A 51chromium isotope release assay for detecting cytotoxicity to human bladder carcinoma , 1977, International journal of cancer.

[21]  M. Cohn,et al.  H‐2 antigen‐specific cytotoxic T cells induced by concanavalin A: estimation of their relative frequency , 1976, European journal of immunology.

[22]  N. Hogg,et al.  Gross‐virus‐induced lymphoma in the rat. IV. Cytotoxic cells in normal rats , 1977, International journal of cancer.

[23]  F. Burnet Immunological aspects of malignant disease. , 1967, Lancet.

[24]  H. Kirchner,et al.  Two functionally distinct anti-tumor effector cells isolated from primary murine sarcoma virus-induced tumors. , 1976, Journal of immunology.

[25]  F. Schlögl Chemical reaction models for non-equilibrium phase transitions , 1972 .

[26]  Michael Feldman,et al.  The frequency of effector cells in populations containing cytotoxic T lymphocytes , 1975 .

[27]  R. Kiessling,et al.  „Natural”︁ killer cells in the mouse. II. Cytotoxic cells with specificity for mouse Moloney leukemia cells. Characteristics of the killer cell , 1975, European journal of immunology.

[28]  J. Remington,et al.  Control of Carcinogenesis: A Possible Role for the Activated Macrophage , 1972, Science.

[29]  J. Cairns,et al.  The cancer problem. , 1975, Scientific American.

[30]  René Lefever,et al.  Comment on the kinetic potential and the maxwell construction in non-equilibrium chemical phase transitions , 1977 .

[31]  E. Klein,et al.  Characterization of human lymphocyte subpopulations for cytotoxicity against tumor‐derived monolayer cultures , 1977, International journal of cancer.